thetaOwl

INTC

Intel CorporationClose $133.99EOD only
Max Pain
$119.00
Next expiry Jun 26, 2026
Expected Move
±$13.47
10.1% from close
Price Gap
-14.99
Distance to max pain
IV Rank
100
High premium
P/C OI
1.05
Balanced positioning
Consensus
7.5/10
Bullish tilt
Published snapshot: Jun 18, 2026 close
End-of-day snapshot

This page reflects INTC options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Jun 18, 2026 close
INTC AI Consensus Report
Analysis based on market close June 18, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Conviction
7.5

out of 10

7.5 not 9 because the anomalous skew and extreme spot-to-max-pain distance create a real reversion threat that tempers the otherwise strong bullish alignment.

Where Perspectives Agree

All personas agree on bullish pinning supported by positive dealer gamma, strong call flow, and high IV, but note the extreme distance from max pain introduces reversion risk.

Where They Diverge

The flow and directional signal sustained upside, while the extreme skew anomaly and spot 123% above max pain imply a sharp reversion risk that contradicts continued rally.

Top Trade
via directional

Sell 2026-08-21 $140 call / buy 2026-09-18 $130 call call diagonal for net debit $1.50

Key Risk

Break below $105 gamma flip triggers dealer gamma selling, accelerating downside to $100 support.

How to Use These Reports
This ai consensus reflects the market close on June 18, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.